Skip to content

Insider · CIK 0001253886

Patrick G Enright

director

Files at JAZZ (Jazz Pharmaceuticals plc), BIOA (BioAge Labs, Inc.), VERA (Vera Therapeutics, Inc.), ZBIO (Zenas BioPharma, Inc.). First filing Jun 25, 2025, latest Dec 15, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
3 / 0
$7.8M bought, $0 sold

Where the trades landed

Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.

VERA: Vera Therapeutics, Inc.

VERAOct 9, 2026 · close 29.88

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

ZBIO: Zenas BioPharma, Inc.

ZBIOOct 9, 2026 · close 27.26

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
36Weak
VERAbuy
Vera Therapeutics, Inc.
$250k
5,882 shares
-+144% from low-1% from high
58Moderate
ZBIObuy 3
Zenas BioPharma, Inc.
$2.3M
117,255 shares
+7%+332% from low0% from high
51Moderate
VERAbuy
Vera Therapeutics, Inc.
$5.3M
250,000 shares
+15%+15% from low-56% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
FTax withholding
Ordinary Shares
-14$244.64$3,42522,97040 d ago
Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
FTax withholding
Ordinary Shares
-1,692$241.39$408k21,27840 d ago
Dec 11, 2025VERA
Vera Therapeutics, Inc.
POpen-market purchase
Class A Common Stock
+5,882$42.50$250k5,882Dec 15, 2025
Oct 9, 2025ZBIO
Zenas BioPharma, Inc.
POpen-market purchase
Common Stockindirect: See Footnote
+105,265$19.00$2.0M1,832,669Oct 14, 2025
Oct 9, 2025ZBIO
Zenas BioPharma, Inc.
POpen-market purchase
Common Stock
+11,990$20.85$250k11,990Oct 14, 2025
Aug 7, 2025JAZZ
Jazz Pharmaceuticals plc
AGrant or award
Ordinary Shares
+3,507$0.00$028,184Aug 11, 2025
Aug 8, 2025JAZZ
Jazz Pharmaceuticals plc
FTax withholding
Ordinary Shares
-1,805$111.25$201k26,379Aug 11, 2025
Jun 23, 2025VERA
Vera Therapeutics, Inc.
POpen-market purchase
Class A Common Stockindirect: See footnote
+69,798$20.87$1.5M1,784,083Jun 25, 2025
Jun 23, 2025VERA
Vera Therapeutics, Inc.
POpen-market purchase
Class A Common Stockindirect: See footnote
+139,595$20.87$2.9M3,569,522Jun 25, 2025
Jun 24, 2025VERA
Vera Therapeutics, Inc.
POpen-market purchase
Class A Common Stockindirect: See footnote
+13,536$22.35$303k1,797,619Jun 25, 2025
Jun 24, 2025VERA
Vera Therapeutics, Inc.
POpen-market purchase
Class A Common Stockindirect: See footnote
+27,071$22.35$605k3,596,593Jun 25, 2025
Jun 10, 2025ZBIO
Zenas BioPharma, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+18,500$0.00$018,500Jun 12, 2025
Jun 5, 2025BIOA
BioAge Labs, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+22,000$0.00$022,000Jun 9, 2025
May 14, 2025VERA
Vera Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+14,000$0.00$014,000May 16, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Patrick G Enright: insider trades and track record | InsiderTell